Nigerian-Born Professor Leads the Launch of New Twice-Yearly HIV Prevention Injection
Lenacapavir is a long-acting HIV prevention drug given as an injection every six months. It now becomes available globally, including in Africa. The new regimen offers a convenient alternative to daily pills. It is expected to boost efforts to curb new HIV infections worldwide. One of the lead researchers is Dr. Ogbuagu, a Nigerian-born Igbo professor at Yale School of Medicine. His team’s work spans HIV/AIDS therapies and major clinical trials for COVID-19 vaccines. The introduction of Lenacapavir highlights the impact of Nigerian scientists in global health research and the value of international collaboration.
Use The App To Win ₦1m
Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.